Cargando…
Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report
Hepatoid adenocarcinoma of the lung (HAL) is a rare extrahepatic tumor characterized by histologic features of hepatocellular carcinoma. The standard treatment for nonresectable HAL has not been established, though traditionally, these tumors have been treated with platinum-based chemotherapy. Here,...
Autores principales: | Lagos, Galina G., Feldman, Jarett L., Saqi, Anjali, Shu, Catherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474391/ https://www.ncbi.nlm.nih.gov/pubmed/34589989 http://dx.doi.org/10.1016/j.jtocrr.2020.100130 |
Ejemplares similares
-
Hepatoid adenocarcinoma of the lung
por: Cavalcante, Lívia Barreira, et al.
Publicado: (2013) -
Hepatoid Adenocarcinoma of the Lung
por: Li, Meihui, et al.
Publicado: (2021) -
Hepatoid Adenocarcinoma Of The Lung Metastasizing To The Gingiva
por: Wang, Chunhua, et al.
Publicado: (2019) -
Treatment of gastric hepatoid adenocarcinoma with pembrolizumab and bevacizumab combination chemotherapy: A case report
por: Liu, Mei, et al.
Publicado: (2022) -
Hepatoid adenocarcinoma of the gallbladder
por: Ellouze , Sameh, et al.
Publicado: (2011)